Altermon (Urofollitropin)

Altermon is a pharmaceutical product containing Urofollitropin, used for reproductive health support. This medication is administered via intramuscular or subcutaneous routes and is manufactured by Faran S.A. in the EU.

Altermon, containing Urofollitropin, is commonly used to support reproductive health. It is often prescribed to aid in ovulation induction or as part of assisted reproductive technologies. Patients may wonder, 'What is Altermon used for?' and the primary applications revolve around fertility treatments and reproductive health management.

Altermon may cause common effects such as injection site reactions, headaches, or mild abdominal discomfort. These effects are generally mild and temporary. Patients should monitor their body's response and consult a healthcare provider if they experience persistent or severe symptoms.

Altermon should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed dosage and administration route, whether intramuscular or subcutaneous. Patients with known allergies to Urofollitropin or similar compounds should avoid using this medication.

Altermon may interact with other medications, particularly those affecting hormonal balance. It is advisable to inform healthcare providers about all current medications, including supplements and over-the-counter drugs. Alcohol and certain CYP inhibitors might also influence the effectiveness or safety of Altermon.